| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | bioactive lipid receptor activity | 8.59e-12 | 16 | 142 | 7 | GO:0045125 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | PLXNA3 EPOR GPR3 LPAR3 GPR6 GPR25 GPR31 F2RL3 OR2G6 OR2C3 OR52P1 PTGER3 ABCA7 S1PR3 S1PR5 ADORA3 NRXN1 NPTXR GPR153 ADGRE3 IL21R P2RY10 LRP6 LRP5 LPAR2 C5AR1 KIR3DL2 GPR132 S1PR4 CXCR2 | 1.94e-08 | 1353 | 142 | 30 | GO:0004888 |
| GeneOntologyMolecularFunction | prolactin receptor binding | 8.44e-08 | 7 | 142 | 4 | GO:0005148 | |
| GeneOntologyMolecularFunction | sphingosine-1-phosphate receptor activity | 1.68e-07 | 8 | 142 | 4 | GO:0038036 | |
| GeneOntologyMolecularFunction | growth hormone receptor binding | 4.98e-07 | 10 | 142 | 4 | GO:0005131 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | GPR3 LPAR3 GPR6 GPR25 GPR31 F2RL3 OR2G6 OR2C3 OR52P1 PTGER3 S1PR3 S1PR5 ADORA3 GPR153 ADGRE3 P2RY10 LPAR2 C5AR1 GPR132 S1PR4 CXCR2 | 1.19e-06 | 884 | 142 | 21 | GO:0004930 |
| GeneOntologyMolecularFunction | hormone receptor binding | 9.63e-05 | 34 | 142 | 4 | GO:0051427 | |
| GeneOntologyMolecularFunction | hormone activity | 4.12e-04 | 135 | 142 | 6 | GO:0005179 | |
| GeneOntologyMolecularFunction | lysophosphatidic acid receptor activity | 4.95e-04 | 5 | 142 | 2 | GO:0070915 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC17A2 TMEM94 FLVCR1 SLC10A3 RTBDN KCNK7 ABCA7 SLC6A9 CACNA2D4 SLC7A3 SLC20A1 SCNN1D TMEM150C KCNK5 LRP6 LRP5 TAP2 SLC2A11 SLC23A3 | 7.06e-04 | 1180 | 142 | 19 | GO:0022857 |
| GeneOntologyBiologicalProcess | positive regulation of steroid hormone biosynthetic process | 1.73e-06 | 13 | 148 | 4 | GO:0090031 | |
| GeneOntologyBiologicalProcess | sphingosine-1-phosphate receptor signaling pathway | 3.27e-06 | 15 | 148 | 4 | GO:0003376 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 5.15e-06 | 224 | 148 | 10 | GO:0007204 | |
| GeneOntologyBiologicalProcess | sphingolipid mediated signaling pathway | 7.20e-06 | 18 | 148 | 4 | GO:0090520 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone biosynthetic process | 9.07e-06 | 19 | 148 | 4 | GO:0046886 | |
| GeneOntologyBiologicalProcess | immunoglobulin production | IGKV1-37 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 PRKDC IGKV1D-37 IGKV1D-13 IGKV1D-12 | 9.80e-06 | 241 | 148 | 10 | GO:0002377 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1.00e-05 | 191 | 148 | 9 | GO:0007189 | |
| GeneOntologyBiologicalProcess | regulation of steroid hormone biosynthetic process | 2.42e-05 | 24 | 148 | 4 | GO:0090030 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway | 3.37e-05 | 26 | 148 | 4 | GO:0060396 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone metabolic process | 3.37e-05 | 26 | 148 | 4 | GO:0032352 | |
| GeneOntologyBiologicalProcess | cellular response to growth hormone stimulus | 3.93e-05 | 27 | 148 | 4 | GO:0071378 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | GPR3 LPAR3 GPR6 GPR25 GPR31 F2RL3 OR2G6 PENK OR2C3 OR52P1 PTGER3 S1PR3 GSK3B S1PR5 ADORA3 GPR153 ADGRE3 ECRG4 P2RY10 LPAR2 C5AR1 GPR132 S1PR4 CXCR2 | 5.57e-05 | 1395 | 148 | 24 | GO:0007186 |
| GeneOntologyBiologicalProcess | positive regulation of D-glucose transmembrane transport | 8.94e-05 | 63 | 148 | 5 | GO:0010828 | |
| GeneOntologyBiologicalProcess | regulation of hormone biosynthetic process | 1.25e-04 | 36 | 148 | 4 | GO:0046885 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid biosynthetic process | 1.55e-04 | 38 | 148 | 4 | GO:0010893 | |
| GeneOntologyBiologicalProcess | response to growth hormone | 2.10e-04 | 41 | 148 | 4 | GO:0060416 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 2.28e-04 | 286 | 148 | 9 | GO:0007188 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid metabolic process | 2.30e-04 | 42 | 148 | 4 | GO:0045940 | |
| GeneOntologyCellularComponent | growth hormone receptor complex | 3.78e-08 | 6 | 150 | 4 | GO:0070195 | |
| GeneOntologyCellularComponent | immunoglobulin complex | IGKV1-37 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 TMIGD2 IGKV1-5 IGKV1D-37 IGKV1D-13 IGKV1D-12 | 3.42e-07 | 166 | 150 | 10 | GO:0019814 |
| GeneOntologyCellularComponent | cell surface | EPOR NT5E PROCR CLSTN2 RTBDN FCN3 PTGER3 ABCA7 ANOS1 CD8A NRXN1 BTNL3 PROM2 CD34 ADGRE3 IL21R ERMAP PKHD1 LRP6 LMAN2 LPAR2 GPC5 C5AR1 NOTCH4 CXCR2 | 3.46e-07 | 1111 | 150 | 25 | GO:0009986 |
| GeneOntologyCellularComponent | Wnt signalosome | 1.89e-04 | 16 | 150 | 3 | GO:1990909 | |
| GeneOntologyCellularComponent | Wnt-Frizzled-LRP5/6 complex | 5.04e-04 | 5 | 150 | 2 | GO:1990851 | |
| GeneOntologyCellularComponent | extracellular matrix | COL6A2 RTBDN FCN3 SVEP1 GH1 SERPINA1 ANOS1 FBLN2 CSH1 CSH2 CSHL1 PRELP GPC5 | 9.12e-04 | 656 | 150 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL6A2 RTBDN FCN3 SVEP1 GH1 SERPINA1 ANOS1 FBLN2 CSH1 CSH2 CSHL1 PRELP GPC5 | 9.37e-04 | 658 | 150 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | external side of plasma membrane | EPOR NT5E RTBDN FCN3 CD8A BTNL3 CD34 IL21R ERMAP PKHD1 CXCR2 | 1.33e-03 | 519 | 150 | 11 | GO:0009897 |
| GeneOntologyCellularComponent | catenin complex | 1.54e-03 | 32 | 150 | 3 | GO:0016342 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL6A2 RTBDN FCN3 GH1 SERPINA1 FBLN2 CSH1 CSH2 CSHL1 PRELP GPC5 | 1.57e-03 | 530 | 150 | 11 | GO:0062023 |
| MousePheno | decreased pituitary gland weight | 2.22e-07 | 8 | 107 | 4 | MP:0008938 | |
| MousePheno | absent somatotrophs | 3.97e-07 | 9 | 107 | 4 | MP:0008330 | |
| MousePheno | absent lactotrophs | 3.97e-07 | 9 | 107 | 4 | MP:0008333 | |
| MousePheno | increased circulating ghrelin level | 1.53e-06 | 12 | 107 | 4 | MP:0011612 | |
| MousePheno | abnormal pituitary gland weight | 1.53e-06 | 12 | 107 | 4 | MP:0008937 | |
| MousePheno | abnormal circulating ghrelin level | 4.15e-06 | 15 | 107 | 4 | MP:0011611 | |
| MousePheno | decreased lactotroph cell number | 7.15e-06 | 17 | 107 | 4 | MP:0008332 | |
| MousePheno | decreased kidney weight | 1.09e-05 | 66 | 107 | 6 | MP:0003918 | |
| MousePheno | abnormal lactotroph morphology | 1.15e-05 | 19 | 107 | 4 | MP:0008323 | |
| MousePheno | decreased somatotroph cell number | 1.76e-05 | 21 | 107 | 4 | MP:0008329 | |
| MousePheno | increased brown adipose tissue amount | 1.83e-05 | 43 | 107 | 5 | MP:0000005 | |
| MousePheno | decreased spleen weight | 2.51e-05 | 113 | 107 | 7 | MP:0004953 | |
| MousePheno | small adenohypophysis | 2.57e-05 | 23 | 107 | 4 | MP:0008321 | |
| MousePheno | abnormal somatotroph morphology | 3.06e-05 | 24 | 107 | 4 | MP:0008322 | |
| MousePheno | increased white adipose tissue amount | 4.67e-05 | 52 | 107 | 5 | MP:0000008 | |
| MousePheno | thin retina outer plexiform layer | 4.97e-05 | 27 | 107 | 4 | MP:0008519 | |
| MousePheno | delayed vaginal opening | 5.77e-05 | 28 | 107 | 4 | MP:0002636 | |
| MousePheno | small pituitary gland | 7.63e-05 | 30 | 107 | 4 | MP:0005361 | |
| MousePheno | abnormal timing of vaginal opening | 8.71e-05 | 31 | 107 | 4 | MP:0020150 | |
| MousePheno | abnormal electroretinogram waveform feature | 1.60e-04 | 106 | 107 | 6 | MP:0012029 | |
| MousePheno | abnormal kidney weight | 1.94e-04 | 208 | 107 | 8 | MP:0002707 | |
| MousePheno | abnormal pituitary gland size | 2.90e-04 | 42 | 107 | 4 | MP:0008936 | |
| MousePheno | abnormal retina rod cell morphology | 3.24e-04 | 78 | 107 | 5 | MP:0001005 | |
| MousePheno | increased small intestinal crypt cell apoptosis | 3.45e-04 | 4 | 107 | 2 | MP:0008800 | |
| MousePheno | enlarged mesenteric lymph nodes | 3.86e-04 | 19 | 107 | 3 | MP:0008466 | |
| MousePheno | abnormal brown adipose tissue amount | 4.09e-04 | 82 | 107 | 5 | MP:0001778 | |
| MousePheno | decreased b-wave amplitude | 4.09e-04 | 82 | 107 | 5 | MP:0012144 | |
| MousePheno | abnormal retina outer plexiform layer morphology | 4.13e-04 | 46 | 107 | 4 | MP:0003732 | |
| MousePheno | abnormal retina blood vessel morphology | 4.29e-04 | 234 | 107 | 8 | MP:0010097 | |
| MousePheno | abnormal b-wave shape | 4.83e-04 | 85 | 107 | 5 | MP:0012035 | |
| MousePheno | abnormal b-wave amplitude | 4.83e-04 | 85 | 107 | 5 | MP:0012031 | |
| MousePheno | delayed sexual maturation | 5.27e-04 | 49 | 107 | 4 | MP:0001938 | |
| MousePheno | abnormal white adipose tissue amount | 6.63e-04 | 138 | 107 | 6 | MP:0001781 | |
| MousePheno | abnormal susceptibility to induced thrombosis | 7.12e-04 | 53 | 107 | 4 | MP:0020408 | |
| Domain | SOMATOTROPIN_2 | 4.36e-08 | 6 | 139 | 4 | PS00338 | |
| Domain | SOMATOTROPIN_1 | 4.36e-08 | 6 | 139 | 4 | PS00266 | |
| Domain | Hormone_1 | 4.36e-08 | 6 | 139 | 4 | PF00103 | |
| Domain | Somatotropin | 1.01e-07 | 7 | 139 | 4 | IPR001400 | |
| Domain | GPCR_Rhodpsn_7TM | GPR3 LPAR3 GPR6 GPR25 GPR31 F2RL3 OR2G6 OR2C3 PTGER3 S1PR3 S1PR5 ADORA3 GPR153 P2RY10 LPAR2 C5AR1 GPR132 S1PR4 CXCR2 | 5.67e-07 | 670 | 139 | 19 | IPR017452 |
| Domain | 7tm_1 | GPR3 LPAR3 GPR6 GPR25 GPR31 F2RL3 OR2G6 OR2C3 PTGER3 S1PR3 S1PR5 ADORA3 GPR153 P2RY10 LPAR2 C5AR1 GPR132 S1PR4 CXCR2 | 6.63e-07 | 677 | 139 | 19 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | GPR3 LPAR3 GPR6 GPR25 GPR31 F2RL3 OR2G6 OR2C3 PTGER3 S1PR3 S1PR5 ADORA3 GPR153 P2RY10 LPAR2 C5AR1 GPR132 S1PR4 CXCR2 | 7.90e-07 | 685 | 139 | 19 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | GPR3 LPAR3 GPR6 GPR25 GPR31 F2RL3 OR2G6 OR2C3 PTGER3 S1PR3 S1PR5 ADORA3 GPR153 P2RY10 LPAR2 C5AR1 GPR132 S1PR4 CXCR2 | 9.00e-07 | 691 | 139 | 19 | PS50262 |
| Domain | GPCR_Rhodpsn | GPR3 LPAR3 GPR6 GPR25 GPR31 F2RL3 OR2G6 OR2C3 PTGER3 S1PR3 S1PR5 ADORA3 GPR153 P2RY10 LPAR2 C5AR1 GPR132 S1PR4 CXCR2 | 9.20e-07 | 692 | 139 | 19 | IPR000276 |
| Domain | S1P_rcpt | 3.99e-06 | 5 | 139 | 3 | IPR004061 | |
| Domain | Somatotropin_CS | 3.99e-06 | 5 | 139 | 3 | IPR018116 | |
| Domain | Cadherin_C | 3.29e-05 | 25 | 139 | 4 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 3.29e-05 | 25 | 139 | 4 | IPR000233 | |
| Domain | LRP5/6 | 5.50e-05 | 2 | 139 | 2 | IPR017049 | |
| Domain | Catenin_binding_dom | 6.04e-05 | 29 | 139 | 4 | IPR027397 | |
| Domain | - | 6.04e-05 | 29 | 139 | 4 | 4.10.900.10 | |
| Domain | GPR_3/6/12_orphan | 1.64e-04 | 3 | 139 | 2 | IPR000723 | |
| Domain | LPA_rcpt | 1.64e-04 | 3 | 139 | 2 | IPR004065 | |
| Domain | EMP70 | 3.27e-04 | 4 | 139 | 2 | PF02990 | |
| Domain | EMP70 | 3.27e-04 | 4 | 139 | 2 | IPR004240 | |
| Domain | EGF | 3.82e-04 | 235 | 139 | 8 | SM00181 | |
| Domain | 4_helix_cytokine_core | 5.60e-04 | 51 | 139 | 4 | IPR012351 | |
| Domain | - | 7.20e-04 | 95 | 139 | 5 | 2.60.120.200 | |
| Domain | Frag1 | 8.09e-04 | 6 | 139 | 2 | PF10277 | |
| Domain | Frag1/DRAM/Sfk1 | 8.09e-04 | 6 | 139 | 2 | IPR019402 | |
| Domain | EGF_CA | 8.68e-04 | 99 | 139 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 9.08e-04 | 100 | 139 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.18e-03 | 106 | 139 | 5 | IPR000152 | |
| Domain | ConA-like_dom | 1.28e-03 | 219 | 139 | 7 | IPR013320 | |
| Domain | Cadherin_pro | 1.50e-03 | 8 | 139 | 2 | SM01055 | |
| Domain | Cadherin_pro_dom | 1.50e-03 | 8 | 139 | 2 | IPR014868 | |
| Domain | CADHERIN_1 | 1.57e-03 | 113 | 139 | 5 | PS00232 | |
| Domain | Cadherin | 1.57e-03 | 113 | 139 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 1.63e-03 | 114 | 139 | 5 | PS50268 | |
| Domain | - | 1.63e-03 | 114 | 139 | 5 | 2.60.40.60 | |
| Domain | CA | 1.69e-03 | 115 | 139 | 5 | SM00112 | |
| Domain | Cadherin-like | 1.76e-03 | 116 | 139 | 5 | IPR015919 | |
| Domain | Cadherin | 1.90e-03 | 118 | 139 | 5 | IPR002126 | |
| Domain | EGF_3 | 1.91e-03 | 235 | 139 | 7 | PS50026 | |
| Domain | MYTH4 | 1.91e-03 | 9 | 139 | 2 | PS51016 | |
| Domain | MyTH4 | 1.91e-03 | 9 | 139 | 2 | SM00139 | |
| Domain | MyTH4_dom | 1.91e-03 | 9 | 139 | 2 | IPR000857 | |
| Domain | 2pore_dom_K_chnl_TASK | 1.91e-03 | 9 | 139 | 2 | IPR003092 | |
| Domain | MyTH4 | 1.91e-03 | 9 | 139 | 2 | PF00784 | |
| Domain | 4_helix_cytokine-like_core | 2.26e-03 | 74 | 139 | 4 | IPR009079 | |
| Domain | EGF-like_Ca-bd_dom | 2.36e-03 | 124 | 139 | 5 | IPR001881 | |
| Domain | IGv | 2.37e-03 | 75 | 139 | 4 | SM00406 | |
| Domain | PTX | 2.38e-03 | 10 | 139 | 2 | SM00159 | |
| Domain | EGF | 2.53e-03 | 126 | 139 | 5 | PF00008 | |
| Domain | EGF-like_dom | 2.65e-03 | 249 | 139 | 7 | IPR000742 | |
| Domain | Pentaxin-related | 2.89e-03 | 11 | 139 | 2 | IPR001759 | |
| Domain | Pentaxin | 2.89e-03 | 11 | 139 | 2 | PF00354 | |
| Domain | LDLR_class-A_CS | 3.26e-03 | 40 | 139 | 3 | IPR023415 | |
| Domain | EGF_CA | 3.89e-03 | 86 | 139 | 4 | PF07645 | |
| Domain | Ldl_recept_a | 4.56e-03 | 45 | 139 | 3 | PF00057 | |
| Domain | Ldl_recept_b | 4.72e-03 | 14 | 139 | 2 | PF00058 | |
| Domain | LDLRB | 4.72e-03 | 14 | 139 | 2 | PS51120 | |
| Domain | - | 4.85e-03 | 46 | 139 | 3 | 4.10.400.10 | |
| Domain | 2pore_dom_K_chnl | 5.42e-03 | 15 | 139 | 2 | IPR003280 | |
| Domain | LY | 5.42e-03 | 15 | 139 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.42e-03 | 15 | 139 | 2 | IPR000033 | |
| Domain | LDLRA_1 | 5.46e-03 | 48 | 139 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 5.79e-03 | 49 | 139 | 3 | IPR002172 | |
| Domain | LDLa | 5.79e-03 | 49 | 139 | 3 | SM00192 | |
| Domain | LDLRA_2 | 5.79e-03 | 49 | 139 | 3 | PS50068 | |
| Domain | EGF_Ca-bd_CS | 5.97e-03 | 97 | 139 | 4 | IPR018097 | |
| Domain | - | 6.12e-03 | 50 | 139 | 3 | 1.20.1250.10 | |
| Domain | ECH_1 | 6.95e-03 | 17 | 139 | 2 | PF00378 | |
| Domain | Crotonase_core_superfam | 6.95e-03 | 17 | 139 | 2 | IPR001753 | |
| Domain | Thioredoxin_CS | 6.95e-03 | 17 | 139 | 2 | IPR017937 | |
| Pathway | WP_GPCRS_NONODORANT | LPAR3 GPR6 F2RL3 PTGER3 S1PR3 S1PR5 ADORA3 ADGRE3 P2RY10 LPAR2 C5AR1 GPR132 S1PR4 CXCR2 | 1.67e-08 | 266 | 109 | 14 | MM15843 |
| Pathway | REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS | 4.77e-08 | 14 | 109 | 5 | M27331 | |
| Pathway | REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS | 4.77e-08 | 14 | 109 | 5 | MM15062 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | LPAR3 GPR31 F2RL3 PENK PTGER3 S1PR3 S1PR5 ADORA3 P2RY10 LPAR2 C5AR1 GPR132 S1PR4 CXCR2 | 2.43e-07 | 330 | 109 | 14 | M18334 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | LPAR3 GPR31 F2RL3 PENK PTGER3 S1PR3 S1PR5 ADORA3 P2RY10 LPAR2 C5AR1 GPR132 S1PR4 CXCR2 | 2.72e-07 | 333 | 109 | 14 | MM14963 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | LPAR3 F2RL3 PTGER3 S1PR3 GH1 S1PR5 ADORA3 CSH1 P2RY10 LPAR2 C5AR1 S1PR4 | 1.24e-06 | 272 | 109 | 12 | M13380 |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 2.29e-06 | 13 | 109 | 4 | MM14516 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | LPAR3 GPR31 F2RL3 PENK PTGER3 S1PR3 S1PR5 ADORA3 ADGRE3 P2RY10 LPAR2 C5AR1 GPR132 S1PR4 CXCR2 | 2.66e-06 | 463 | 109 | 15 | M507 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | LPAR3 GPR31 F2RL3 PENK PTGER3 S1PR3 S1PR5 ADORA3 P2RY10 LPAR2 C5AR1 GPR132 S1PR4 CXCR2 | 5.58e-06 | 430 | 109 | 14 | MM15160 |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 5.73e-06 | 16 | 109 | 4 | MM15710 | |
| Pathway | BIOCARTA_LONGEVITY_PATHWAY | 1.20e-05 | 19 | 109 | 4 | MM1513 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | LPAR3 GPR31 PENK PTGER3 S1PR3 S1PR5 ADORA3 LPAR2 C5AR1 S1PR4 CXCR2 | 1.44e-05 | 289 | 109 | 11 | MM15057 |
| Pathway | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | 1.49e-05 | 20 | 109 | 4 | MM15070 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 2.45e-05 | 8 | 109 | 3 | MM14976 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | LPAR3 GPR25 GPR31 F2RL3 PENK PTGER3 S1PR3 S1PR5 ADORA3 ADGRE3 P2RY10 LPAR2 C5AR1 ARHGEF37 GPR132 S1PR4 CXCR2 | 2.60e-05 | 702 | 109 | 17 | M746 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | LPAR3 GPR31 PENK PTGER3 S1PR3 S1PR5 ADORA3 LPAR2 C5AR1 S1PR4 CXCR2 | 3.10e-05 | 314 | 109 | 11 | M600 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | LPAR3 GPR25 GPR31 F2RL3 PENK PTGER3 S1PR3 S1PR5 ADORA3 P2RY10 LPAR2 C5AR1 ARHGEF37 GPR132 S1PR4 CXCR2 | 3.52e-05 | 646 | 109 | 16 | MM14962 |
| Pathway | BIOCARTA_AKT_PATHWAY | 4.43e-05 | 26 | 109 | 4 | MM1345 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 6.92e-05 | 29 | 109 | 4 | MM1522 | |
| Pathway | BIOCARTA_GH_PATHWAY | 1.16e-04 | 33 | 109 | 4 | MM1404 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 1.31e-04 | 34 | 109 | 4 | M27405 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.84e-04 | 260 | 109 | 9 | M39397 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 1.91e-04 | 15 | 109 | 3 | M27273 | |
| Pathway | REACTOME_PEPTIDE_HORMONE_METABOLISM | 2.05e-04 | 70 | 109 | 5 | MM14916 | |
| Pathway | WP_GPCRS_SMALL_LIGAND | 3.37e-04 | 18 | 109 | 3 | MM15858 | |
| Pathway | WP_SMALL_LIGAND_GPCRS | 3.98e-04 | 19 | 109 | 3 | M39728 | |
| Pathway | PID_S1P_META_PATHWAY | 5.40e-04 | 21 | 109 | 3 | M155 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 5.76e-04 | 133 | 109 | 6 | M16476 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS | 5.83e-04 | 5 | 109 | 2 | M48304 | |
| Pathway | REACTOME_SIGNALING_BY_LRP5_MUTANTS | 8.71e-04 | 6 | 109 | 2 | M27432 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 9.51e-04 | 326 | 109 | 9 | MM15917 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA | 1.03e-03 | 26 | 109 | 3 | M39407 | |
| Pubmed | 1.25e-12 | 10 | 151 | 6 | 12401212 | ||
| Pubmed | Lysophospholipid receptor nomenclature review: IUPHAR Review 8. | 2.94e-11 | 15 | 151 | 6 | 24602016 | |
| Pubmed | 1.08e-10 | 18 | 151 | 6 | 20399194 | ||
| Pubmed | 1.79e-10 | 9 | 151 | 5 | 19398579 | ||
| Pubmed | 1.38e-09 | 75 | 151 | 8 | 2834384 | ||
| Pubmed | Central growth hormone action regulates metabolism during pregnancy. | 1.70e-09 | 5 | 151 | 4 | 31479305 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 10767558 | ||
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 18006625 | ||
| Pubmed | Growth hormone prevents the development of autoimmune diabetes. | 1.70e-09 | 5 | 151 | 4 | 24218587 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 9546108 | ||
| Pubmed | Transgene transmission to progeny by oMt1a-oGH transgenic mice. | 1.70e-09 | 5 | 151 | 4 | 16201410 | |
| Pubmed | Genes that prolong life: relationships of growth hormone and growth to aging and life span. | 1.70e-09 | 5 | 151 | 4 | 11487592 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 11318985 | ||
| Pubmed | Identification of the glomerular podocyte as a target for growth hormone action. | 1.70e-09 | 5 | 151 | 4 | 17272398 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 20707609 | ||
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 1874564 | ||
| Pubmed | Growth Hormone Deficiency and Excess Alter the Gut Microbiome in Adult Male Mice. | 1.70e-09 | 5 | 151 | 4 | 32100023 | |
| Pubmed | Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies. | 1.70e-09 | 5 | 151 | 4 | 10810296 | |
| Pubmed | Somatotropin transgenic mice have reduced jejunal active glucose transport rates. | 1.70e-09 | 5 | 151 | 4 | 7965203 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 17347312 | ||
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 21852148 | ||
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 12175649 | ||
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 15070902 | ||
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 14726450 | ||
| Pubmed | UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences. | 1.70e-09 | 5 | 151 | 4 | 24758742 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 10076541 | ||
| Pubmed | Overgrowth of skin in growth hormone transgenic mice depends on the presence of male gonads. | 1.70e-09 | 5 | 151 | 4 | 10594738 | |
| Pubmed | Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes. | 1.70e-09 | 5 | 151 | 4 | 23639351 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 21098290 | ||
| Pubmed | Age-related changes in body composition of bovine growth hormone transgenic mice. | 1.70e-09 | 5 | 151 | 4 | 18948397 | |
| Pubmed | Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. | 1.70e-09 | 5 | 151 | 4 | 8496314 | |
| Pubmed | Exploring endocrine GH pattern in mice using rank plot analysis and random blood samples. | 1.70e-09 | 5 | 151 | 4 | 21045135 | |
| Pubmed | Analysis of gender difference of cardiac risk biomarkers using hGH-transgenic mice. | 1.70e-09 | 5 | 151 | 4 | 16508206 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 15616010 | ||
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 19019400 | ||
| Pubmed | The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH? | 1.70e-09 | 5 | 151 | 4 | 32556100 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 1525063 | ||
| Pubmed | Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice. | 1.70e-09 | 5 | 151 | 4 | 11346667 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 12010633 | ||
| Pubmed | Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis. | 1.70e-09 | 5 | 151 | 4 | 17626886 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 19359380 | ||
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 15316240 | ||
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 17301034 | ||
| Pubmed | Growth hormone action in the developing neural retina: a proteomic analysis. | 1.70e-09 | 5 | 151 | 4 | 18203262 | |
| Pubmed | Assignment of the porcine growth hormone gene to chromosome 12. | 1.70e-09 | 5 | 151 | 4 | 2249485 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 17242167 | ||
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 18180319 | ||
| Pubmed | Cloning and characterisation of the GH gene from the common dolphin (Delphinus delphis). | 1.70e-09 | 5 | 151 | 4 | 12225773 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 3780533 | ||
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 10395045 | ||
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 24190208 | ||
| Pubmed | Brief report: short stature caused by a mutant growth hormone. | 1.70e-09 | 5 | 151 | 4 | 8552145 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 36762426 | ||
| Pubmed | High molecular weight isoforms of growth hormone in cells of the immune system. | 1.70e-09 | 5 | 151 | 4 | 21741628 | |
| Pubmed | Structure of the growth hormone-encoding gene and its promoter in mice. | 1.70e-09 | 5 | 151 | 4 | 8647448 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 26887678 | ||
| Pubmed | The role of growth hormone in fetal mouse reproductive tract differentiation. | 1.70e-09 | 5 | 151 | 4 | 8756530 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 31099824 | ||
| Pubmed | Hot spots for growth hormone gene deletions in homologous regions outside of Alu repeats. | 1.70e-09 | 5 | 151 | 4 | 1980158 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 17881271 | ||
| Pubmed | Neural growth hormone implicated in body weight sex differences. | 1.70e-09 | 5 | 151 | 4 | 23861378 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 12759574 | ||
| Pubmed | Growth hormone production and action in N1E-115 neuroblastoma cells. | 1.70e-09 | 5 | 151 | 4 | 19301152 | |
| Pubmed | Adipocyte insensitivity to insulin in growth hormone-transgenic mice. | 1.70e-09 | 5 | 151 | 4 | 11350075 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 18617616 | ||
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 11570960 | ||
| Pubmed | Promoter shuffling has occurred during the evolution of the vertebrate growth hormone gene. | 1.70e-09 | 5 | 151 | 4 | 10974531 | |
| Pubmed | 1.70e-09 | 5 | 151 | 4 | 23428905 | ||
| Pubmed | Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH. | 1.70e-09 | 5 | 151 | 4 | 17761891 | |
| Pubmed | Expression patterns of the lysophospholipid receptor genes during mouse early development. | 1.81e-09 | 13 | 151 | 5 | 18924241 | |
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 12399427 | ||
| Pubmed | GH modulates hepatic epidermal growth factor signaling in the mouse. | 5.09e-09 | 6 | 151 | 4 | 20032199 | |
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 11316754 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 23150490 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 2991252 | ||
| Pubmed | Third party data gene data set of eutherian growth hormone genes. | 5.09e-09 | 6 | 151 | 4 | 26697363 | |
| Pubmed | Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse. | 5.09e-09 | 6 | 151 | 4 | 15985453 | |
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 20863500 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 12208853 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 9175714 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 16141391 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 18618017 | ||
| Pubmed | Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. | 5.09e-09 | 6 | 151 | 4 | 14759511 | |
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 15166120 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 24691732 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 38951485 | ||
| Pubmed | Evidence that growth hormone exerts a feedback effect on stomach ghrelin production and secretion. | 5.09e-09 | 6 | 151 | 4 | 14530511 | |
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 21849508 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 33368660 | ||
| Pubmed | Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. | 5.09e-09 | 6 | 151 | 4 | 14702113 | |
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 9556071 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 8990189 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 12933669 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 22890843 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 15138153 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 30333823 | ||
| Pubmed | GH/STAT5 signaling during the growth period in livers of mice overexpressing GH. | 5.09e-09 | 6 | 151 | 4 | 25691498 | |
| Pubmed | The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice. | 5.09e-09 | 6 | 151 | 4 | 23349524 | |
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 26762506 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 25811804 | ||
| Interaction | CSH1 interactions | 1.16e-07 | 18 | 139 | 5 | int:CSH1 | |
| Interaction | MARCHF4 interactions | 1.09e-06 | 112 | 139 | 8 | int:MARCHF4 | |
| Interaction | SLC17A2 interactions | 2.36e-06 | 56 | 139 | 6 | int:SLC17A2 | |
| Interaction | CSH2 interactions | 2.79e-06 | 15 | 139 | 4 | int:CSH2 | |
| Interaction | GH1 interactions | 3.70e-06 | 16 | 139 | 4 | int:GH1 | |
| Interaction | CSHL1 interactions | 1.10e-05 | 7 | 139 | 3 | int:CSHL1 | |
| Interaction | HLA-G interactions | 1.78e-05 | 118 | 139 | 7 | int:HLA-G | |
| Interaction | IL5RA interactions | 2.45e-05 | 124 | 139 | 7 | int:IL5RA | |
| Interaction | SIRPD interactions | 2.89e-05 | 86 | 139 | 6 | int:SIRPD | |
| Interaction | KLK3 interactions | 5.85e-05 | 60 | 139 | 5 | int:KLK3 | |
| Interaction | TNFRSF10C interactions | 7.98e-05 | 103 | 139 | 6 | int:TNFRSF10C | |
| Cytoband | 2p12 | IGKV1-37 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 CD8A IGKV1D-37 IGKV1D-13 IGKV1D-12 | 7.23e-12 | 117 | 151 | 10 | 2p12 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | IGKV1-37 IGKV1-13 IGKV1-12 TRABD2A IGKV1-9 IGKV1-6 IGKV1-5 CD8A IGKV1D-37 IGKV1D-13 IGKV1D-12 | 1.51e-10 | 213 | 151 | 11 | chr2p11 |
| Cytoband | 17q24.2 | 2.88e-06 | 30 | 151 | 4 | 17q24.2 | |
| Cytoband | 1q32 | 5.75e-04 | 49 | 151 | 3 | 1q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 6.87e-04 | 120 | 151 | 4 | chr17q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.36e-03 | 797 | 151 | 9 | chr19p13 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | IGKV1-37 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-37 IGKV1D-13 IGKV1D-12 | 2.75e-09 | 83 | 115 | 9 | 351 |
| GeneFamily | Growth hormone family | 2.31e-08 | 6 | 115 | 4 | 1175 | |
| GeneFamily | Sphingosine 1-phosphate receptors|CD molecules | 2.48e-06 | 5 | 115 | 3 | 206 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 1.03e-05 | 78 | 115 | 6 | 262 | |
| GeneFamily | Transmembrane 9 superfamily members | 2.39e-04 | 4 | 115 | 2 | 1239 | |
| GeneFamily | CD molecules|Type I classical cadherins | 3.96e-04 | 5 | 115 | 2 | 1185 | |
| GeneFamily | Lysophosphatidic acid receptors | 5.92e-04 | 6 | 115 | 2 | 205 | |
| GeneFamily | Low density lipoprotein receptors | 2.99e-03 | 13 | 115 | 2 | 634 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.70e-03 | 394 | 115 | 8 | 471 | |
| GeneFamily | Solute carriers | SLC17A2 FLVCR1 SLC10A3 SLC6A9 SLC7A3 SLC20A1 SLC2A11 SLC23A3 | 3.75e-03 | 395 | 115 | 8 | 752 |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 3.99e-03 | 15 | 115 | 2 | 458 | |
| GeneFamily | Potassium two pore domain channel subfamily K | 3.99e-03 | 15 | 115 | 2 | 277 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 1.63e-05 | 27 | 150 | 4 | M1391 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 1.63e-05 | 27 | 150 | 4 | MM1135 | |
| Coexpression | GSE3982_MAST_CELL_VS_MAC_UP | 2.01e-05 | 199 | 150 | 8 | M5429 | |
| Coexpression | GSE3039_NKT_CELL_VS_B2_BCELL_UP | 2.08e-05 | 200 | 150 | 8 | M6435 | |
| Coexpression | ZAMORA_NOS2_TARGETS_UP | 2.43e-05 | 60 | 150 | 5 | MM1165 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-37 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 TERT IGKV1-5 IGKV1D-37 IGKV1D-13 IGKV1D-12 | 1.22e-09 | 194 | 150 | 10 | 6ef4aeb8d8e35e4df58ff2a8256caa2113291de9 |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL6A2 PENK PTGER3 S1PR3 S1PR5 FBLN2 NRXN1 PRELP ECRG4 ALDH1A1 | 1.42e-09 | 197 | 150 | 10 | 05e303fff86db31f7b742324c64980eb2b9cff9a |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-08 | 184 | 150 | 9 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-37 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-37 IGKV1D-13 IGKV1D-12 | 2.20e-08 | 195 | 150 | 9 | f3f7f1a77a1edd2b50a8211c76fe289738eb04cf |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-08 | 198 | 150 | 9 | cfe2d52b19a1b4c2c2076fa1d5a69baf21a49623 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.62e-08 | 199 | 150 | 9 | f19c683f38bca3bfee40396f27423441051dec67 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-08 | 152 | 150 | 8 | d88d68a788a3256671ebbc06e104833f1f58f07d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-08 | 152 | 150 | 8 | d5ba87b5d34e52cef8475befafea962d70fa8a1d | |
| ToppCell | wk_15-18-Epithelial-PNS-intermediate_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.07e-07 | 183 | 150 | 8 | d874aa9a856f79626c8a8371f6196a77b7d662ee | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-07 | 184 | 150 | 8 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-07 | 188 | 150 | 8 | 1cd5a4d744bd3777246958ea5eb94388a5cbad81 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-07 | 188 | 150 | 8 | c32d023a69b6da79687ff8fa7485e7499db57046 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-07 | 190 | 150 | 8 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-07 | 190 | 150 | 8 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-07 | 190 | 150 | 8 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-07 | 193 | 150 | 8 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-07 | 193 | 150 | 8 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-07 | 193 | 150 | 8 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-07 | 194 | 150 | 8 | da926441053b499cb5107ccb116fb1b3844d82b7 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-07 | 194 | 150 | 8 | f34b3bbdebf56f66ff499e390e5515a4a4093f90 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 3.22e-07 | 194 | 150 | 8 | c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-07 | 194 | 150 | 8 | 54a7f693966b5c02f6b248950ddb5fa32af3ae67 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue | 3.35e-07 | 195 | 150 | 8 | c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 3.48e-07 | 196 | 150 | 8 | a3b077e82b1550eb328c84b567b60179001f9a77 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 3.48e-07 | 196 | 150 | 8 | 1868ad537b7f04cdad0a0c8282aadbc4f257a722 | |
| ToppCell | Influenza_Severe-NK|World / Disease group and Cell class | 3.62e-07 | 197 | 150 | 8 | 565d578f7a28a19175d56663bf30c60e0d5e1b22 | |
| ToppCell | severe_influenza-NK|World / disease group, cell group and cell class (v2) | 3.62e-07 | 197 | 150 | 8 | 8e86a1ee0418e153d4f0bf291006cffc6cf36f71 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 P2RY10 IGKV1D-13 IGKV1D-12 | 3.62e-07 | 197 | 150 | 8 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.76e-07 | 198 | 150 | 8 | c72ef2ddcbb6dacbed4c6200d89e17d57314dcdc | |
| ToppCell | (0)_NK_cells-(0)_NK_FCGR3Apos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.76e-07 | 198 | 150 | 8 | eba39656c6f699ab297b652ded8cb9727b49593c | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic-Chondrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.76e-07 | 198 | 150 | 8 | 55f013e9e6587d9ece59751fa131b1d22d6cceea | |
| ToppCell | mLN-Macrophage|mLN / Region, Cell class and subclass | 4.06e-07 | 200 | 150 | 8 | 68d709afd226241e002dae6d6820bccd1cfd87a1 | |
| ToppCell | mLN-(6)_Macrophage|mLN / shred on region, Cell_type, and subtype | 4.06e-07 | 200 | 150 | 8 | 6dcba82a7d322102bae205543086e84c7655b3e0 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-06 | 157 | 150 | 7 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-06 | 170 | 150 | 7 | ee2ee67d90ae4596de8ccd620e37c82cf51651d4 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-06 | 170 | 150 | 7 | d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-06 | 170 | 150 | 7 | 52787f6d529c285d9f0c04cc022710ead5b89b3f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-06 | 172 | 150 | 7 | cf46810dd1072b6f2171e5d9530351ddc79a055b | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 176 | 150 | 7 | fc51e4dcad5456c229d76fdcb9a80c4c79eacf3f | |
| ToppCell | IPF-Lymphoid-B_Plasma|IPF / Disease state, Lineage and Cell class | IGKV1-37 IGKV1-13 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-13 IGKV1D-12 | 2.29e-06 | 176 | 150 | 7 | e4f33f6cd140dd4fa3002bcd65ac8005d27865d1 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | IGKV1-9 IGKV1-6 SLC6A9 IGKV1-5 IGKV1D-37 IGKV1D-13 IGKV1D-12 | 2.37e-06 | 177 | 150 | 7 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.37e-06 | 177 | 150 | 7 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGKV1-9 IGKV1-6 SLC6A9 IGKV1-5 IGKV1D-37 IGKV1D-13 IGKV1D-12 | 2.37e-06 | 177 | 150 | 7 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGKV1-9 IGKV1-6 SLC6A9 IGKV1-5 IGKV1D-37 IGKV1D-13 IGKV1D-12 | 2.37e-06 | 177 | 150 | 7 | fc40918825b7e1eb6861df59dfca944778a64b98 |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.56e-06 | 179 | 150 | 7 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-3|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.56e-06 | 179 | 150 | 7 | f36776299e570345e18dc38cdef4cfc90e7ed7c2 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-9 IGKV1-6 SLC6A9 IGKV1-5 IGKV1D-37 IGKV1D-13 IGKV1D-12 | 2.56e-06 | 179 | 150 | 7 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 182 | 150 | 7 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-06 | 182 | 150 | 7 | 1bf2e4fd6222b41a7d08df6dcc500c9401db8c18 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 182 | 150 | 7 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-06 | 183 | 150 | 7 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-06 | 184 | 150 | 7 | 7e129862f8d2353387999e633725325c4d8cb42e | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.29e-06 | 186 | 150 | 7 | 7812ed80d2378aca9957ef22fc3c8fb7fb58434b | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | IGKV1-9 IGKV1-6 SLC6A9 IGKV1-5 IGKV1D-37 IGKV1D-13 IGKV1D-12 | 3.29e-06 | 186 | 150 | 7 | e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67 |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-06 | 187 | 150 | 7 | b6ecf55014f246461bf1ca12f24cb4d046661fa4 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-06 | 187 | 150 | 7 | 9fb15f24b9b364b0c4704ec98aec236eaec5411c | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.41e-06 | 187 | 150 | 7 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-06 | 187 | 150 | 7 | e6afbaed352310a1cb49571a2aae18be1f533c9a | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-06 | 187 | 150 | 7 | 1669df899b1759c338ffce196fe009840123cfcd | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-06 | 187 | 150 | 7 | f3ef3f5a761f8306edc39bf16e76e44aae6fa7f6 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | IGKV1-9 IGKV1-6 SLC6A9 IGKV1-5 IGKV1D-37 IGKV1D-13 IGKV1D-12 | 3.54e-06 | 188 | 150 | 7 | bd53b0371154cff680226897b61c9809a239d1b6 |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-06 | 189 | 150 | 7 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-06 | 189 | 150 | 7 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-06 | 189 | 150 | 7 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.79e-06 | 190 | 150 | 7 | 0eef5a8bd88ef8a25a67d9dd522d9472fa4b3d2f | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.79e-06 | 190 | 150 | 7 | 9a2244c3973aee7270646bf00db7727edb9decc5 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.79e-06 | 190 | 150 | 7 | 11fbd4e9f02750354b3aadf30edc991f8d4f8f41 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.79e-06 | 190 | 150 | 7 | 148d43dd72e2e22b2cd68e17fedae6bd98b32aee | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.79e-06 | 190 | 150 | 7 | 2724e8f375d8d9f5f2a77444e0491af264babac5 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.92e-06 | 191 | 150 | 7 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM1|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.92e-06 | 191 | 150 | 7 | bd641aab36276dd952a7265ee79ba455b38d8e6b | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.92e-06 | 191 | 150 | 7 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | IPF-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 3.92e-06 | 191 | 150 | 7 | f2ddc0962007d7a4e78fbd916ebb62fc557d480a | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-06 | 192 | 150 | 7 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.06e-06 | 192 | 150 | 7 | f68e6cbde87678122da1b5c0061904cfb7d04bf5 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 192 | 150 | 7 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.06e-06 | 192 | 150 | 7 | 1922b0350d3375e67c314dbce8074e5cf986f2ef | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.06e-06 | 192 | 150 | 7 | a4d161e3d48bc020e687808b352325ef9d1cc1f3 | |
| ToppCell | facs-BAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 192 | 150 | 7 | 0b3161ce3add9f7457f4cfa5749dbb6501e3ad36 | |
| ToppCell | facs-BAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 192 | 150 | 7 | 61c7ec6171c519b2f3e9ce623669162c0c6ba9f5 | |
| ToppCell | facs-BAT-Fat-24m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 192 | 150 | 7 | 24d682e3247a73d349e7776b9e564b6b57f4cb13 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.06e-06 | 192 | 150 | 7 | 97c197643e59835c6d45dde9e549c9a1b1bb7288 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.20e-06 | 193 | 150 | 7 | 2661ad9107ed9231e4afea4442a79051139a31df | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-06 | 193 | 150 | 7 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 4.20e-06 | 193 | 150 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-13 IGKV1D-12 | 4.20e-06 | 193 | 150 | 7 | 34f6c13884fdf7f8a87f942fcb36a58cfac3f65d |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.35e-06 | 194 | 150 | 7 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.35e-06 | 194 | 150 | 7 | 9bd25ea57f2da27bd200d1a8bf797fec77d172c7 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 4.35e-06 | 194 | 150 | 7 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.35e-06 | 194 | 150 | 7 | 79baee8b35b7707bbeb07c73b5e17b68bcd7bbc2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.35e-06 | 194 | 150 | 7 | f6e348f1f35c526cad6c349f1fdd0bd92d18aa3c | |
| ToppCell | Mild-CD8+_T|Mild / Disease group and Cell class | 4.35e-06 | 194 | 150 | 7 | c3dba9ff0ab98b6a955b32d071ad7e397dcdc6e9 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.35e-06 | 194 | 150 | 7 | eb279e0d922de921343f0ae032a809f837d915b3 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.35e-06 | 194 | 150 | 7 | a4a70369541876e1192df8828b63e3d1746ae3d9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.35e-06 | 194 | 150 | 7 | ce599ed0dc181aea0584e426636de5098f34ebe6 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.50e-06 | 195 | 150 | 7 | ca2cf2c10db1ad17aa0a2e30aa7079a7ad751ea6 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 195 | 150 | 7 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue | 4.50e-06 | 195 | 150 | 7 | e756733cf48768bf40058d6cf9039e52f7563133 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.50e-06 | 195 | 150 | 7 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | facs-Heart-LA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-06 | 196 | 150 | 7 | 8a84aeb1a565dd3e2a690fcaf1ab804f5e253545 | |
| Drug | AC1L4P7I | 1.71e-08 | 28 | 141 | 6 | CID000189746 | |
| Drug | dhS1P | 3.10e-06 | 65 | 141 | 6 | CID000000520 | |
| Drug | AC1L1JYL | GPR3 LPAR3 GPR6 SPINT1 PROCR ABCA7 S1PR3 S1PR5 CD8A PCSK7 LPAR2 GPR132 S1PR4 | 3.18e-06 | 434 | 141 | 13 | CID000005262 |
| Drug | SureCN160413 | 4.69e-06 | 40 | 141 | 5 | CID011446521 | |
| Drug | AC1MPVH8 | 6.76e-06 | 43 | 141 | 5 | CID003441849 | |
| Drug | lysosphingomyelin | 7.16e-06 | 160 | 141 | 8 | CID000005263 | |
| Drug | gly-pro | 9.46e-06 | 119 | 141 | 7 | CID000079101 | |
| Disease | isolated growth hormone deficiency type II (implicated_via_orthology) | 2.49e-09 | 5 | 141 | 4 | DOID:0060872 (implicated_via_orthology) | |
| Disease | isolated growth hormone deficiency (implicated_via_orthology) | 1.73e-08 | 7 | 141 | 4 | DOID:0060870 (implicated_via_orthology) | |
| Disease | osteoporosis (biomarker_via_orthology) | 5.72e-08 | 22 | 141 | 5 | DOID:11476 (biomarker_via_orthology) | |
| Disease | congenital hypothyroidism (biomarker_via_orthology) | 4.82e-07 | 14 | 141 | 4 | DOID:0050328 (biomarker_via_orthology) | |
| Disease | Azotemia | 2.27e-05 | 2 | 141 | 2 | C0242528 | |
| Disease | type 1 diabetes mellitus (implicated_via_orthology) | 3.61e-05 | 39 | 141 | 4 | DOID:9744 (implicated_via_orthology) | |
| Disease | posterior thigh muscle volume | 4.66e-05 | 15 | 141 | 3 | EFO_0020931 | |
| Disease | Disorder of eye | 7.50e-05 | 212 | 141 | 7 | C0015397 | |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 3.21e-04 | 28 | 141 | 3 | DOID:0050866 (is_implicated_in) | |
| Disease | Polycythemia | 6.23e-04 | 8 | 141 | 2 | C0032461 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 7.20e-04 | 147 | 141 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Erythrocytosis | 7.98e-04 | 9 | 141 | 2 | C1527405 | |
| Disease | ulcerative colitis | 1.18e-03 | 335 | 141 | 7 | EFO_0000729 | |
| Disease | Liver Cirrhosis, Experimental | SLC17A2 COL6A2 NT5E PROCR NAT8 GH1 ADORA3 SLC20A1 C5AR1 ALDH1A1 TAP2 | 1.27e-03 | 774 | 141 | 11 | C0023893 |
| Disease | Mental Depression | 1.43e-03 | 254 | 141 | 6 | C0011570 | |
| Disease | ficolin-3 measurement | 1.45e-03 | 12 | 141 | 2 | EFO_0020392 | |
| Disease | anemia (is_implicated_in) | 1.99e-03 | 14 | 141 | 2 | DOID:2355 (is_implicated_in) | |
| Disease | Muscular Atrophy | 2.29e-03 | 15 | 141 | 2 | C0026846 | |
| Disease | Neurogenic Muscular Atrophy | 2.29e-03 | 15 | 141 | 2 | C0270948 | |
| Disease | longevity | 2.50e-03 | 284 | 141 | 6 | EFO_0004300 | |
| Disease | Libman-Sacks Disease | 2.72e-03 | 58 | 141 | 3 | C0242380 | |
| Disease | Depressive disorder | 2.73e-03 | 289 | 141 | 6 | C0011581 | |
| Disease | mean arterial pressure | 2.83e-03 | 499 | 141 | 8 | EFO_0006340 | |
| Disease | Multiple congenital anomalies | 2.94e-03 | 17 | 141 | 2 | C0000772 | |
| Disease | protein C measurement | 2.94e-03 | 17 | 141 | 2 | EFO_0004633 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 3.29e-03 | 62 | 141 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | Schizophrenia | PTGER3 GSK3B SLC6A9 NRXN1 GPR153 TMEM245 ALDH1A1 TAP2 DKK4 NOTCH4 SLC23A3 | 3.51e-03 | 883 | 141 | 11 | C0036341 |
| Disease | prostate carcinoma | TERT CLDN23 SERPINA1 SLC7A3 SLC20A1 PKHD1 KDM2A CDYL GPC5 PLEKHH2 NOTCH4 | 3.76e-03 | 891 | 141 | 11 | EFO_0001663 |
| Disease | urate measurement | NR2E3 PCNX3 BIRC6 CLDN23 TFDP2 CACNA2D4 NRXN1 PKHD1 KCNK5 LMAN2 TAP2 | 3.89e-03 | 895 | 141 | 11 | EFO_0004531 |
| Disease | Hemorrhage | 4.07e-03 | 20 | 141 | 2 | C0019080 | |
| Disease | Severe Combined Immunodeficiency | 4.07e-03 | 20 | 141 | 2 | C0085110 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPILLLSGWAFCSQD | 6 | Q9UNN8 | |
| SPWRLASILLGLLCG | 231 | Q6UXE8 | |
| WLLLGTLPKVVSLCG | 41 | Q7Z695 | |
| LALLLLLCWGPGGIS | 16 | Q9H1Z8 | |
| ILCGPVWLASGLDLS | 1181 | Q9NR09 | |
| LGLCWLVSFLVGLTP | 131 | P0DMS8 | |
| GLVWQPLCSLAKALL | 341 | A1IGU5 | |
| SWGILLLAGLCCLVP | 6 | P01009 | |
| CGVWAVALLAGLPSL | 161 | O00155 | |
| LSPQAALGVSGLVWL | 126 | O00270 | |
| LAFALLCLPWLQEAG | 11 | Q14406 | |
| LIWKIGPALSCGNTV | 176 | P00352 | |
| WAPLAGTCGVLLLSL | 186 | P01732 | |
| ACAVAWGLALLLTIP | 156 | P21730 | |
| LCWVPLLLALGVGSG | 6 | Q9H4D0 | |
| PSGSWNGALCRLLLL | 6 | Q02487 | |
| LPSAGTVPWLQGLIC | 61 | Q8IZY2 | |
| FLLGAIQWSLPLDSC | 261 | Q9Y5X4 | |
| GPLLKSGETVILQCW | 131 | P43630 | |
| TLCTWLLLLGPGLLA | 6 | P01210 | |
| PSDILQGLLGNCWFL | 541 | O75808 | |
| LSELGPICAREGLWL | 256 | P19113 | |
| WLLLLGGPACLKTQE | 11 | O75636 | |
| PGAVLTLCLWLAASS | 6 | P23352 | |
| GPGALEILWLTLCQF | 251 | Q8NF37 | |
| GLLLPAVNPWDVLLC | 66 | P46095 | |
| SLGLGLLPVLGWNCL | 196 | P46095 | |
| SLGCVIAELFLGWPL | 386 | Q9H2X6 | |
| VASLLGQPWLCLGLG | 131 | Q9HCP6 | |
| GQPWLCLGLGLASLA | 136 | Q9HCP6 | |
| GLLLLWFPGSRCDIQ | 11 | P01611 | |
| GPLTGWRVFLLLLCA | 316 | Q12907 | |
| WTPGQVVLLLDGLGC | 251 | Q9HBW0 | |
| LPWGCDVQGSLSSLL | 886 | Q9NPP4 | |
| LPLISVALVQGWALG | 146 | Q9NTX5 | |
| WPVGFRCLLLLALVG | 6 | P78333 | |
| VAAPLCLLWLSPQGA | 346 | Q9BYJ1 | |
| CLLWLSPQGALVPLA | 351 | Q9BYJ1 | |
| GLLLLWVPGARCDIQ | 11 | P0DSN7 | |
| VLVNASLGWPNGLAL | 496 | O75197 | |
| PALVLWGLQGDCSLL | 186 | Q9Y2U2 | |
| GLLLLWLPGARCAIQ | 11 | A0A0B4J2D9 | |
| LAFALLCLPWLQEAG | 11 | P0DML3 | |
| WLALGLALALGPSVA | 11 | P98095 | |
| CLLIWLLDALGSAQP | 866 | Q9H6A9 | |
| GLPTCLWLELAGLFL | 16 | Q16549 | |
| GTLALPWLLNKELPC | 361 | P51805 | |
| FGVPLCLTWISALGK | 121 | O95279 | |
| AALLLISLPWGAQGT | 31 | P09131 | |
| CIGWLALTDLVGQLL | 91 | P43115 | |
| ISDAKGILQCLLWGP | 1656 | Q9H792 | |
| CLSIWGLSLLLALPV | 166 | P25025 | |
| VCGGLSLLANAWGIL | 16 | Q6NV75 | |
| GLISTALAGPWANIC | 11 | O14960 | |
| CWTPGLVVLLLDGLN | 251 | Q9UBY5 | |
| GPVGLLWLSLAKNCF | 511 | Q8N4P6 | |
| VSGLLSPDGLACDWL | 91 | O75581 | |
| LLLLRASCPWGQEQG | 11 | Q13087 | |
| LSLLLLGCWAELGSG | 16 | Q9ULB1 | |
| LCLGLALASWLGGLT | 141 | Q8N628 | |
| GLEQFHLWLSLPVCG | 21 | Q8NH57 | |
| HLWLSLPVCGLGTAT | 26 | Q8NH57 | |
| CLAGAWVATVIGLPL | 61 | Q6ZMK1 | |
| IANCTAPLLGNVLPW | 461 | O95502 | |
| GLGLLPVLAWNCLDG | 166 | P46089 | |
| AAGCGSALLWPRLLL | 6 | Q2TAA2 | |
| QGWQLLALCVGLFLP | 1041 | Q8IVE3 | |
| GLPANGLALWVLATQ | 91 | Q96RI0 | |
| LLLWVTGQAAPVAGL | 16 | O95302 | |
| PLWPGSSEGLQLLVC | 46 | Q5W5W9 | |
| LLGGPQAWPLLLASC | 181 | Q9BYW1 | |
| QAWPLLLASCLVPGA | 186 | Q9BYW1 | |
| LPGLKDLLLAGCSWS | 976 | Q9Y2K7 | |
| GLGASILPLCDVVWA | 451 | Q9Y232 | |
| LLGLSWLCSPLGALV | 6 | Q9UBT3 | |
| LLLLGTSLSPAWGQA | 56 | Q7Z3S7 | |
| GPFLILCPLSVLSNW | 96 | Q86WJ1 | |
| CSVLLLWGILGAIQA | 6 | P12110 | |
| WSAGCVLAELLLGQP | 241 | P49841 | |
| NIAILTPLLGLTWGF | 651 | Q8IZF7 | |
| TALLGSGLNCLGAWI | 176 | Q9Y5Y0 | |
| TPLATISGWLCLRGA | 156 | Q86UD3 | |
| GQSPKECLRLWLSNG | 356 | P32019 | |
| ASLWPQVGSLCLLLA | 6 | P19235 | |
| GLLLLWLPGAKCDIQ | 11 | P01602 | |
| GLLLLWLPGARCAIQ | 11 | A0A0C4DH72 | |
| GLLLLWLPGARCDIQ | 11 | A0A0C4DH69 | |
| GLLLLWFPGSRCDIQ | 11 | A0A0C4DH73 | |
| GLLLLWLPGARCAIQ | 11 | P0DP09 | |
| GLLLLWVPGARCDIQ | 11 | A0A075B6S9 | |
| AAPLLLLLLQGGWGC | 6 | Q9HBE5 | |
| LLLLQGGWGCPDLVC | 11 | Q9HBE5 | |
| LAFALLCLPWLQEAG | 11 | P0DML2 | |
| CWLIAFTLGALPILG | 161 | Q99500 | |
| FTLGALPILGWNCLH | 166 | Q99500 | |
| LVCWGPLFGLLLADV | 261 | O95977 | |
| AAAWGVSLLLGLLPA | 156 | Q9H228 | |
| VSLLLGLLPALGWNC | 161 | Q9H228 | |
| LPLWGTILISVGCAV | 226 | Q8WUM9 | |
| LLLAWNPICLGLVEG | 36 | Q9Y2H2 | |
| SLGALVALCWQLGLL | 256 | P51172 | |
| LLAQSLCLSLGVPGW | 11 | P55291 | |
| GPLASLLLLQVCWLQ | 6 | P22223 | |
| LGIPLLWPCLGATEN | 11 | Q9H159 | |
| GWTALCLLSLLPSGF | 16 | P28906 | |
| CGLLLNLTGTLAPGW | 16 | Q96B33 | |
| LCLVLAQWSVPLLSG | 491 | Q8WY07 | |
| GLSPLCAIGLWTDIS | 551 | Q16531 | |
| IPGLLANSAALWVLC | 46 | O00398 | |
| GGAWLSGLITSLIQC | 146 | Q5TZ20 | |
| GVPANCLTAWLALLQ | 56 | Q9UNW8 | |
| VNWPAIGSLLGCLIR | 266 | Q96C03 | |
| LLGGTAELLCPLSLW | 41 | Q96PL5 | |
| TRWAGKGLLGCNIIP | 206 | O00233 | |
| AWILLEACGGSRPLQ | 21 | Q9BSG5 | |
| LASGCKNGQILLWDP | 171 | Q9NVX2 | |
| PWLGLLLCCVLTSVG | 101 | Q96HV5 | |
| PNQLILWTGLLCALG | 86 | A6NC51 | |
| LCGATLLWRTPAGLL | 296 | Q8N2H9 | |
| GLLLLLWGSCTFGLP | 11 | P00797 | |
| LAWCFLLALSPQAPG | 21 | Q8TEB7 | |
| DAALLWLLQGPLGTL | 16 | Q03519 | |
| CWLLPLLILASVAQG | 6 | P51888 | |
| WLAGCGTELPLITAR | 746 | P08F94 | |
| NPWLNISGLVALCLA | 96 | B9EJG8 | |
| SIILCLPNGLWSGSE | 416 | Q4LDE5 | |
| LQLLWPSNPGCLFLE | 866 | Q12769 | |
| LQGWTGPLCNLPLSS | 871 | Q99466 | |
| VAWSLSLCGDLGLPL | 436 | Q5JTZ9 | |
| DISTGPSWLNQGLLL | 351 | Q14188 | |
| LGVCLSLGPWTVLSA | 81 | Q3YBM2 | |
| GSLPWGLSCLLALQH | 41 | Q6PIS1 | |
| ALLALGLPGWVLAVS | 21 | Q9C0B6 | |
| TLLLALGAVLWPAAG | 11 | P21589 | |
| LGCTWCLGLLQVGPA | 561 | Q9BY15 | |
| CPLGQALWAGLALIQ | 71 | Q6UE05 | |
| LFWALLCLLGTGPVE | 6 | A0A5A2 | |
| CGPQLTALLAAWIAA | 6 | Q9H1E5 | |
| LVGLAPSGARWTCLQ | 131 | Q96KV7 | |
| LSLGVCGPQGRLSWQ | 76 | Q96BF3 | |
| PLSLVLLVCGWICGL | 101 | A6NFC5 | |
| WLLALAGGVILLCSG | 26 | Q03395 | |
| LCNLLGLNLGIWGLS | 441 | Q8N271 | |
| GLEDVPLLTWLLGCL | 1301 | Q12767 | |
| GIPAVALWLLCTLGL | 16 | O43278 | |
| ALWLLCTLGLQGTQA | 21 | O43278 | |
| ILCVGGLISQALSWP | 196 | O00624 | |
| LAFGLLCLPWLQEGS | 11 | P01241 | |
| LLPCLLGVGSWLLFN | 96 | Q8N816 | |
| VRLPLLGCLGVSWLV | 286 | P48067 | |
| WFLLQTLCLLPTGAA | 6 | Q86V40 | |
| CSGPGWLLSLSALLS | 16 | Q96AE7 | |
| GPFSLQATLCWLDLL | 1246 | P78527 | |
| PAVLDLWLTQGLGCK | 761 | Q9H330 | |
| TCAVVLWVLLGTPAG | 401 | Q99805 | |
| VALEGLDGLCLPALW | 11 | Q12789 | |
| LVLVAALWGGTQPLL | 11 | Q8WY98 | |
| GLFPWCGLLLDTRTL | 926 | O14746 | |
| LANGLQLLCPWAPLS | 176 | O95231 | |
| SCQWLPILILLLGTG | 11 | O15321 | |
| LGSLGITWCFLESPL | 6 | Q8N3U1 | |
| LLWLCTGLFPPSNIL | 1836 | Q13402 | |
| LLGGPLALLLVSGSW | 46 | Q9UHE5 |